ZA200602156B - Improvements in vaccination - Google Patents

Info

Publication number

ZA200602156B

ZA200602156B ZA200602156A ZA200602156A ZA200602156B ZA 200602156 B ZA200602156 B ZA 200602156B ZA 200602156 A ZA200602156 A ZA 200602156A ZA 200602156 A ZA200602156 A ZA 200602156A ZA 200602156 B ZA200602156 B ZA 200602156B

Authority

ZA

South Africa

Prior art keywords

nucleotide sequence

component

encoding

protein

nucleotide

Prior art date

2003-09-15

Links

• Espacenet
• Global Dossier
• Discuss

• 238000002255 vaccination Methods 0.000 title description 11
• 230000006872 improvement Effects 0.000 title description 4
• 239000002773 nucleotide Substances 0.000 claims description 164
• 125000003729 nucleotide group Chemical group 0.000 claims description 163
• 239000000203 mixture Substances 0.000 claims description 151
• 239000000556 agonist Substances 0.000 claims description 117
• 230000002163 immunogen Effects 0.000 claims description 106
• 108090000623 proteins and genes Proteins 0.000 claims description 99
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 95
• 239000002671 adjuvant Substances 0.000 claims description 87
• 238000000034 method Methods 0.000 claims description 81
• 239000000427 antigen Substances 0.000 claims description 76
• 102000036639 antigens Human genes 0.000 claims description 73
• 108091007433 antigens Proteins 0.000 claims description 73
• DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims description 72
• 102100034256 Mucin-1 Human genes 0.000 claims description 71
• 229960002751 imiquimod Drugs 0.000 claims description 65
• 102000004169 proteins and genes Human genes 0.000 claims description 63
• 108091033319 polynucleotide Proteins 0.000 claims description 59
• 239000002157 polynucleotide Substances 0.000 claims description 59
• 102000040430 polynucleotide Human genes 0.000 claims description 59
• 230000028993 immune response Effects 0.000 claims description 55
• 239000013598 vector Substances 0.000 claims description 54
• 108010008707 Mucin-1 Proteins 0.000 claims description 51
• 239000013612 plasmid Substances 0.000 claims description 50
• 230000000890 antigenic effect Effects 0.000 claims description 46
• 108020004414 DNA Proteins 0.000 claims description 42
• 229940124669 imidazoquinoline Drugs 0.000 claims description 41
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 40
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 40
• -1 hyaluronan oligosaccharides Chemical class 0.000 claims description 37
• 206010028980 Neoplasm Diseases 0.000 claims description 35
• 241000124008 Mammalia Species 0.000 claims description 33
• 102000002689 Toll-like receptor Human genes 0.000 claims description 31
• 108020000411 Toll-like receptor Proteins 0.000 claims description 31
• SQQXRXKYTKFFSM-UHFFFAOYSA-N chembl1992147 Chemical compound OC1=C(OC)C(OC)=CC=C1C1=C(C)C(C(O)=O)=NC(C=2N=C3C4=NC(C)(C)N=C4C(OC)=C(O)C3=CC=2)=C1N SQQXRXKYTKFFSM-UHFFFAOYSA-N 0.000 claims description 31
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 29
• 229960005486 vaccine Drugs 0.000 claims description 28
• 230000008569 process Effects 0.000 claims description 27
• 238000004519 manufacturing process Methods 0.000 claims description 24
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 23
• 239000003814 drug Substances 0.000 claims description 23
• 239000002158 endotoxin Substances 0.000 claims description 22
• 229920006008 lipopolysaccharide Polymers 0.000 claims description 21
• 201000010099 disease Diseases 0.000 claims description 20
• BXNMTOQRYBFHNZ-UHFFFAOYSA-N resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 claims description 20
• 239000008194 pharmaceutical composition Substances 0.000 claims description 19
• 229950010550 resiquimod Drugs 0.000 claims description 19
• 230000001580 bacterial effect Effects 0.000 claims description 18
• 239000012634 fragment Substances 0.000 claims description 18
• 239000002245 particle Substances 0.000 claims description 18
• 238000011282 treatment Methods 0.000 claims description 18
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 17
• 239000011324 bead Substances 0.000 claims description 17
• 150000001875 compounds Chemical class 0.000 claims description 16
• 239000003085 diluting agent Substances 0.000 claims description 14
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 14
• 239000010931 gold Substances 0.000 claims description 14
• 229910052737 gold Inorganic materials 0.000 claims description 14
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
• 201000008827 tuberculosis Diseases 0.000 claims description 13
• 229940035032 monophosphoryl lipid a Drugs 0.000 claims description 12
• 239000000969 carrier Substances 0.000 claims description 11
• 241000894007 species Species 0.000 claims description 11
• 241000894006 Bacteria Species 0.000 claims description 9
• 108010028921 Lipopeptides Proteins 0.000 claims description 9
• 108020001507 fusion proteins Proteins 0.000 claims description 9
• 102000037865 fusion proteins Human genes 0.000 claims description 9
• 230000001404 mediated effect Effects 0.000 claims description 9
• 210000002307 prostate Anatomy 0.000 claims description 9
• 238000001727 in vivo Methods 0.000 claims description 8
• 230000001965 increasing effect Effects 0.000 claims description 8
• 108090001030 Lipoproteins Proteins 0.000 claims description 7
• 102000004895 Lipoproteins Human genes 0.000 claims description 7
• 108700006640 OspA Proteins 0.000 claims description 7
• 239000002253 acid Substances 0.000 claims description 7
• 150000007513 acids Chemical class 0.000 claims description 7
• 231100000252 nontoxic Toxicity 0.000 claims description 7
• 230000003000 nontoxic effect Effects 0.000 claims description 7
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 6
• 108010040721 Flagellin Proteins 0.000 claims description 6
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims description 6
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
• 102100039360 Toll-like receptor 4 Human genes 0.000 claims description 6
• 230000013595 glycosylation Effects 0.000 claims description 6
• 238000006206 glycosylation reaction Methods 0.000 claims description 6
• 108010067306 Fibronectins Proteins 0.000 claims description 5
• 238000011321 prophylaxis Methods 0.000 claims description 5
• 210000004881 tumor cell Anatomy 0.000 claims description 5
• 101710163595 Chaperone protein DnaK Proteins 0.000 claims description 4
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 4
• 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims description 4
• 101710113864 Heat shock protein 90 Proteins 0.000 claims description 4
• 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 claims description 4
• 101100481584 Mus musculus Tlr1 gene Proteins 0.000 claims description 4
• 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 4
• 241000588653 Neisseria Species 0.000 claims description 4
• 230000000840 anti-viral effect Effects 0.000 claims description 4
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 3
• ZAPSNGHNEPUZEG-UHFFFAOYSA-N 1-(4-amino-2-methylimidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol Chemical compound C1=CC=CC2=C(N(C(C)=N3)CC(C)(C)O)C3=C(N)N=C21 ZAPSNGHNEPUZEG-UHFFFAOYSA-N 0.000 claims description 3
• VDCRFBBZFHHYGT-IOSLPCCCSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-3h-purine-6,8-dione Chemical compound O=C1N(CC=C)C=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VDCRFBBZFHHYGT-IOSLPCCCSA-N 0.000 claims description 3
• 108010059013 Chaperonin 10 Proteins 0.000 claims description 3
• 102000008946 Fibrinogen Human genes 0.000 claims description 3
• 108010049003 Fibrinogen Proteins 0.000 claims description 3
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 3
• 229920002971 Heparan sulfate Polymers 0.000 claims description 3
• 201000005505 Measles Diseases 0.000 claims description 3
• 102000017033 Porins Human genes 0.000 claims description 3
• 108010013381 Porins Proteins 0.000 claims description 3
• 241000191967 Staphylococcus aureus Species 0.000 claims description 3
• 229940124614 TLR 8 agonist Drugs 0.000 claims description 3
• 229920000392 Zymosan Polymers 0.000 claims description 3
• 210000001224 bacterial fimbriae Anatomy 0.000 claims description 3
• 238000012377 drug delivery Methods 0.000 claims description 3
• 229940012952 fibrinogen Drugs 0.000 claims description 3
• 229940099552 hyaluronan Drugs 0.000 claims description 3
• 229920002674 hyaluronan Polymers 0.000 claims description 3
• 229950005634 loxoribine Drugs 0.000 claims description 3
• 201000005296 lung carcinoma Diseases 0.000 claims description 3
• 238000002156 mixing Methods 0.000 claims description 3
• 229920001542 oligosaccharide Polymers 0.000 claims description 3
• 229940115272 polyinosinic:polycytidylic acid Drugs 0.000 claims description 3
• QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
• 210000002845 virion Anatomy 0.000 claims description 3
• 239000000304 virulence factor Substances 0.000 claims description 3
• 230000007923 virulence factor Effects 0.000 claims description 3
• 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 claims description 2
• 108010058432 Chaperonin 60 Proteins 0.000 claims description 2
• 201000003741 Gastrointestinal carcinoma Diseases 0.000 claims description 2
• 102000007615 Pulmonary Surfactant-Associated Protein A Human genes 0.000 claims description 2
• 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 claims description 2
• 229940124615 TLR 7 agonist Drugs 0.000 claims description 2
• 201000008275 breast carcinoma Diseases 0.000 claims description 2
• 208000018554 digestive system carcinoma Diseases 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 230000002708 enhancing effect Effects 0.000 claims description 2
• 230000002496 gastric effect Effects 0.000 claims description 2
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 2
• 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 11
• 102000016359 Fibronectins Human genes 0.000 claims 2
• 230000004044 response Effects 0.000 description 81
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 77
• 125000004432 carbon atom Chemical group C* 0.000 description 77
• 210000004027 cell Anatomy 0.000 description 65
• 108020004705 Codon Proteins 0.000 description 49
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 49
• 238000002649 immunization Methods 0.000 description 49
• 235000018102 proteins Nutrition 0.000 description 49
• 230000014509 gene expression Effects 0.000 description 41
• 241000699670 Mus sp. Species 0.000 description 38
• 125000000217 alkyl group Chemical group 0.000 description 37
• 238000009472 formulation Methods 0.000 description 36
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 31
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 30
• CTMZLDSMFCVUNX-VMIOUTBZSA-N cytidylyl-(3'->5')-guanosine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(N=C(N)N3)=O)N=C2)O)[C@@H](CO)O1 CTMZLDSMFCVUNX-VMIOUTBZSA-N 0.000 description 29
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 25
• 230000011664 signaling Effects 0.000 description 25
• 239000001257 hydrogen Substances 0.000 description 24
• 229910052739 hydrogen Inorganic materials 0.000 description 24
• 108091034117 Oligonucleotide Proteins 0.000 description 22
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 21
• 125000003545 alkoxy group Chemical group 0.000 description 21
• 150000001413 amino acids Chemical class 0.000 description 20
• 229940024606 amino acid Drugs 0.000 description 19
• 235000001014 amino acid Nutrition 0.000 description 19
• 241000282414 Homo sapiens Species 0.000 description 18
• 150000002431 hydrogen Chemical class 0.000 description 18
• 150000007523 nucleic acids Chemical class 0.000 description 18
• 102000004127 Cytokines Human genes 0.000 description 17
• 108090000695 Cytokines Proteins 0.000 description 17
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 17
• 239000002953 phosphate buffered saline Substances 0.000 description 17
• 239000006071 cream Substances 0.000 description 16
• 101100346932 Mus musculus Muc1 gene Proteins 0.000 description 15
• 102000039446 nucleic acids Human genes 0.000 description 14
• 108020004707 nucleic acids Proteins 0.000 description 14
• 108700010070 Codon Usage Proteins 0.000 description 13
• 241001465754 Metazoa Species 0.000 description 13
• 241000700605 Viruses Species 0.000 description 13
• 210000004443 dendritic cell Anatomy 0.000 description 13
• 229910052736 halogen Inorganic materials 0.000 description 13
• 150000002367 halogens Chemical class 0.000 description 13
• 210000004988 splenocyte Anatomy 0.000 description 13
• 230000000638 stimulation Effects 0.000 description 13
• 238000002474 experimental method Methods 0.000 description 12
• 238000011238 DNA vaccination Methods 0.000 description 11
• 102000000588 Interleukin-2 Human genes 0.000 description 11
• 108010058846 Ovalbumin Proteins 0.000 description 11
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 11
• 108010002350 Interleukin-2 Proteins 0.000 description 10
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 10
• 238000010276 construction Methods 0.000 description 10
• 208000002672 hepatitis B Diseases 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 125000001424 substituent group Chemical group 0.000 description 10
• 210000004369 blood Anatomy 0.000 description 9
• 239000008280 blood Substances 0.000 description 9
• 229920001184 polypeptide Polymers 0.000 description 9
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
• 238000011510 Elispot assay Methods 0.000 description 8
• 239000004480 active ingredient Substances 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 230000036755 cellular response Effects 0.000 description 8
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 8
• 239000013604 expression vector Substances 0.000 description 8
• 230000004927 fusion Effects 0.000 description 8
• 238000000338 in vitro Methods 0.000 description 8
• 230000003834 intracellular effect Effects 0.000 description 8
• 229940092253 ovalbumin Drugs 0.000 description 8
• 239000000843 powder Substances 0.000 description 8
• 238000011160 research Methods 0.000 description 8
• 239000003053 toxin Substances 0.000 description 8
• 231100000765 toxin Toxicity 0.000 description 8
• 108700012359 toxins Proteins 0.000 description 8
• JVJGCCBAOOWGEO-RUTPOYCXSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-4-amino-2-[[(2s,3s)-2-[[(2s,3s)-2-[[(2s)-2-azaniumyl-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumy Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 JVJGCCBAOOWGEO-RUTPOYCXSA-N 0.000 description 7
• 208000023275 Autoimmune disease Diseases 0.000 description 7
• 108010029697 CD40 Ligand Proteins 0.000 description 7
• 102100032937 CD40 ligand Human genes 0.000 description 7
• 241000701022 Cytomegalovirus Species 0.000 description 7
• 206010020751 Hypersensitivity Diseases 0.000 description 7
• 241000699666 Mus <mouse, genus> Species 0.000 description 7
• 230000004913 activation Effects 0.000 description 7
• 230000007815 allergy Effects 0.000 description 7
• 210000004899 c-terminal region Anatomy 0.000 description 7
• 201000011510 cancer Diseases 0.000 description 7
• 210000004970 cd4 cell Anatomy 0.000 description 7
• 239000003795 chemical substances by application Substances 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 230000003248 secreting effect Effects 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 210000001519 tissue Anatomy 0.000 description 7
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• 241000588724 Escherichia coli Species 0.000 description 6
• 241000725303 Human immunodeficiency virus Species 0.000 description 6
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
• 102100034872 Kallikrein-4 Human genes 0.000 description 6
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 125000000753 cycloalkyl group Chemical group 0.000 description 6
• 230000000694 effects Effects 0.000 description 6
• 230000001976 improved effect Effects 0.000 description 6
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 6
• 108010024383 kallikrein 4 Proteins 0.000 description 6
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
• 244000309715 mini pig Species 0.000 description 6
• 229940023146 nucleic acid vaccine Drugs 0.000 description 6
• 230000001105 regulatory effect Effects 0.000 description 6
• 230000028327 secretion Effects 0.000 description 6
• 210000000952 spleen Anatomy 0.000 description 6
• 238000010186 staining Methods 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 6
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 5
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 5
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 5
• 125000004183 alkoxy alkyl group Chemical group 0.000 description 5
• 238000013459 approach Methods 0.000 description 5
• 238000010367 cloning Methods 0.000 description 5
• 239000011248 coating agent Substances 0.000 description 5
• 238000000576 coating method Methods 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• 210000004962 mammalian cell Anatomy 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 238000012737 microarray-based gene expression Methods 0.000 description 5
• 238000012243 multiplex automated genomic engineering Methods 0.000 description 5
• 108091008146 restriction endonucleases Proteins 0.000 description 5
• 239000003826 tablet Substances 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 230000003612 virological effect Effects 0.000 description 5
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• 208000035143 Bacterial infection Diseases 0.000 description 4
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 4
• 102000011022 Chorionic Gonadotropin Human genes 0.000 description 4
• 108010062540 Chorionic Gonadotropin Proteins 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 108010041986 DNA Vaccines Proteins 0.000 description 4
• 229940021995 DNA vaccine Drugs 0.000 description 4
• 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 4
• 101150106931 IFNG gene Proteins 0.000 description 4
• 108010075205 OVA-8 Proteins 0.000 description 4
• 108700023315 OspC Proteins 0.000 description 4
• 101710188053 Protein D Proteins 0.000 description 4
• 108010076504 Protein Sorting Signals Proteins 0.000 description 4
• 101100431670 Rattus norvegicus Ybx3 gene Proteins 0.000 description 4
• 101710132893 Resolvase Proteins 0.000 description 4
• 102000012479 Serine Proteases Human genes 0.000 description 4
• 108010022999 Serine Proteases Proteins 0.000 description 4
• 208000036142 Viral infection Diseases 0.000 description 4
• 210000001015 abdomen Anatomy 0.000 description 4
• 238000007792 addition Methods 0.000 description 4
• 230000000240 adjuvant effect Effects 0.000 description 4
• 125000003342 alkenyl group Chemical group 0.000 description 4
• 208000026935 allergic disease Diseases 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 229940015047 chorionic gonadotropin Drugs 0.000 description 4
• 230000009089 cytolysis Effects 0.000 description 4
• 230000001086 cytosolic effect Effects 0.000 description 4
• 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 4
• 239000007789 gas Substances 0.000 description 4
• 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
• 230000006698 induction Effects 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 239000004615 ingredient Substances 0.000 description 4
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 4
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
• 230000002685 pulmonary effect Effects 0.000 description 4
• 238000007920 subcutaneous administration Methods 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 239000004094 surface-active agent Substances 0.000 description 4
• 238000012360 testing method Methods 0.000 description 4
• 238000011200 topical administration Methods 0.000 description 4
• 230000000699 topical effect Effects 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• 230000009385 viral infection Effects 0.000 description 4
• 239000013603 viral vector Substances 0.000 description 4
• 238000005406 washing Methods 0.000 description 4
• 241000589968 Borrelia Species 0.000 description 3
• 241000606161 Chlamydia Species 0.000 description 3
• 102100037362 Fibronectin Human genes 0.000 description 3
• 241000606768 Haemophilus influenzae Species 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 3
• 241000701806 Human papillomavirus Species 0.000 description 3
• 108050006617 Interleukin-1 receptor Proteins 0.000 description 3
• 102000019223 Interleukin-1 receptor Human genes 0.000 description 3
• 108010065805 Interleukin-12 Proteins 0.000 description 3
• 102000013462 Interleukin-12 Human genes 0.000 description 3
• 108090000176 Interleukin-13 Proteins 0.000 description 3
• 102000003816 Interleukin-13 Human genes 0.000 description 3
• 108090000978 Interleukin-4 Proteins 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• 208000016604 Lyme disease Diseases 0.000 description 3
• 101150053046 MYD88 gene Proteins 0.000 description 3
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 101500027983 Rattus norvegicus Octadecaneuropeptide Proteins 0.000 description 3
• 102100039390 Toll-like receptor 7 Human genes 0.000 description 3
• 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 3
• 208000006673 asthma Diseases 0.000 description 3
• 208000022362 bacterial infectious disease Diseases 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 231100000135 cytotoxicity Toxicity 0.000 description 3
• 230000003013 cytotoxicity Effects 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical group [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 210000002919 epithelial cell Anatomy 0.000 description 3
• 210000003743 erythrocyte Anatomy 0.000 description 3
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 239000008187 granular material Substances 0.000 description 3
• 208000006454 hepatitis Diseases 0.000 description 3
• 231100000283 hepatitis Toxicity 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 230000003308 immunostimulating effect Effects 0.000 description 3
• 230000001024 immunotherapeutic effect Effects 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 230000004073 interleukin-2 production Effects 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 210000001165 lymph node Anatomy 0.000 description 3
• 230000035800 maturation Effects 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 210000001616 monocyte Anatomy 0.000 description 3
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 230000008488 polyadenylation Effects 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 230000004043 responsiveness Effects 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 210000003491 skin Anatomy 0.000 description 3
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 3
• 230000009261 transgenic effect Effects 0.000 description 3
• 230000003827 upregulation Effects 0.000 description 3
• 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 description 2
• HQBUPOAKJGJGCD-UHFFFAOYSA-N 3h-imidazo[4,5-c]quinolin-4-amine Chemical compound NC1=NC2=CC=CC=C2C2=C1N=CN2 HQBUPOAKJGJGCD-UHFFFAOYSA-N 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 206010059313 Anogenital warts Diseases 0.000 description 2
• 108030001720 Bontoxilysin Proteins 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
• 101710132601 Capsid protein Proteins 0.000 description 2
• 208000017667 Chronic Disease Diseases 0.000 description 2
• 241000193403 Clostridium Species 0.000 description 2
• 208000035473 Communicable disease Diseases 0.000 description 2
• 208000000907 Condylomata Acuminata Diseases 0.000 description 2
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 241000700721 Hepatitis B virus Species 0.000 description 2
• 208000007514 Herpes zoster Diseases 0.000 description 2
• 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 2
• 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 102000003814 Interleukin-10 Human genes 0.000 description 2
• 108090000174 Interleukin-10 Proteins 0.000 description 2
• 108010002616 Interleukin-5 Proteins 0.000 description 2
• 102000000743 Interleukin-5 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 241000186781 Listeria Species 0.000 description 2
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 2
• 101710127797 Macrophage colony-stimulating factor 1 Proteins 0.000 description 2
• 101710105759 Major outer membrane porin Proteins 0.000 description 2
• 101710164702 Major outer membrane protein Proteins 0.000 description 2
• 101710085938 Matrix protein Proteins 0.000 description 2
• 241000712079 Measles morbillivirus Species 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 101710127721 Membrane protein Proteins 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 241000711386 Mumps virus Species 0.000 description 2
• 101000746372 Mus musculus Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 2
• 101001043827 Mus musculus Interleukin-2 Proteins 0.000 description 2
• 101000944608 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Chaperonin GroEL 2 Proteins 0.000 description 2
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
• 208000030852 Parasitic disease Diseases 0.000 description 2
• 241000224016 Plasmodium Species 0.000 description 2
• 241000223960 Plasmodium falciparum Species 0.000 description 2
• 102100035181 Plastin-1 Human genes 0.000 description 2
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
• 102100038358 Prostate-specific antigen Human genes 0.000 description 2
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
• 239000012979 RPMI medium Substances 0.000 description 2
• 241000725643 Respiratory syncytial virus Species 0.000 description 2
• 241000607142 Salmonella Species 0.000 description 2
• 101150052859 Slc9a1 gene Proteins 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 101150057615 Syn gene Proteins 0.000 description 2
• 230000024932 T cell mediated immunity Effects 0.000 description 2
• 108010055044 Tetanus Toxin Proteins 0.000 description 2
• 102100033110 Toll-like receptor 8 Human genes 0.000 description 2
• 101800000385 Transmembrane protein Proteins 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 125000004423 acyloxy group Chemical group 0.000 description 2
• 125000005041 acyloxyalkyl group Chemical group 0.000 description 2
• 235000019270 ammonium chloride Nutrition 0.000 description 2
• 238000000137 annealing Methods 0.000 description 2
• 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 2
• 201000004201 anogenital venereal wart Diseases 0.000 description 2
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
• MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 229940053031 botulinum toxin Drugs 0.000 description 2
• 210000000481 breast Anatomy 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000011203 carbon fibre reinforced carbon Chemical group 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 230000000139 costimulatory effect Effects 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000007402 cytotoxic response Effects 0.000 description 2
• 238000002784 cytotoxicity assay Methods 0.000 description 2
• 231100000263 cytotoxicity test Toxicity 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 150000002016 disaccharides Chemical group 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 210000002615 epidermis Anatomy 0.000 description 2
• 101150020570 fbpC gene Proteins 0.000 description 2
• 229940028334 follicle stimulating hormone Drugs 0.000 description 2
• 229960002442 glucosamine Drugs 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 102000022382 heparin binding proteins Human genes 0.000 description 2
• 108091012216 heparin binding proteins Proteins 0.000 description 2
• 230000006801 homologous recombination Effects 0.000 description 2
• 238000002744 homologous recombination Methods 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 201000004792 malaria Diseases 0.000 description 2
• 229940124735 malaria vaccine Drugs 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000000465 moulding Methods 0.000 description 2
• 210000003928 nasal cavity Anatomy 0.000 description 2
• 229940100662 nasal drops Drugs 0.000 description 2
• 210000004681 ovum Anatomy 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 150000004713 phosphodiesters Chemical class 0.000 description 2
• 239000013600 plasmid vector Substances 0.000 description 2
• 108010049148 plastin Proteins 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 229940118376 tetanus toxin Drugs 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 230000000451 tissue damage Effects 0.000 description 2
• 231100000827 tissue damage Toxicity 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241000712461 unidentified influenza virus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• CNBOKXFMODKQCT-UHFFFAOYSA-N 1-(4-aminoimidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol Chemical compound C1=CC=CC2=C3N(CC(C)(O)C)C=NC3=C(N)N=C21 CNBOKXFMODKQCT-UHFFFAOYSA-N 0.000 description 1
• LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
• MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
• RHKWIGHJGOEUSM-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinoline Chemical class C1=CN=C2C(N=CN3)=C3C=CC2=C1 RHKWIGHJGOEUSM-UHFFFAOYSA-N 0.000 description 1
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
• 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 1
• 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 1
• 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 1
• 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 102000006822 Agouti Signaling Protein Human genes 0.000 description 1
• 108010072151 Agouti Signaling Protein Proteins 0.000 description 1
• 102000054930 Agouti-Related Human genes 0.000 description 1
• 101710127426 Agouti-related protein Proteins 0.000 description 1
• 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 1
• 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
• 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 1
• 101100162403 Arabidopsis thaliana ALEU gene Proteins 0.000 description 1
• 240000005528 Arctium lappa Species 0.000 description 1
• 102100024630 Asc-type amino acid transporter 1 Human genes 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 1
• 102100035526 B melanoma antigen 1 Human genes 0.000 description 1
• 241000223836 Babesia Species 0.000 description 1
• 241000304886 Bacilli Species 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 1
• 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 1
• 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 1
• 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 1
• 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 1
• 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 1
• 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 1
• 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 1
• 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 1
• 241000588807 Bordetella Species 0.000 description 1
• 241000588779 Bordetella bronchiseptica Species 0.000 description 1
• 241000588780 Bordetella parapertussis Species 0.000 description 1
• 241000588832 Bordetella pertussis Species 0.000 description 1
• 241000589978 Borrelia hermsii Species 0.000 description 1
• 241000495356 Borrelia microti Species 0.000 description 1
• 241001148604 Borreliella afzelii Species 0.000 description 1
• 241000142472 Borreliella andersonii Species 0.000 description 1
• 241000589969 Borreliella burgdorferi Species 0.000 description 1
• 241001148605 Borreliella garinii Species 0.000 description 1
• 241000589893 Brachyspira hyodysenteriae Species 0.000 description 1
• 238000011749 CBA mouse Methods 0.000 description 1
• 101150016835 CPL1 gene Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 241000589876 Campylobacter Species 0.000 description 1
• 241000589877 Campylobacter coli Species 0.000 description 1
• 241000589875 Campylobacter jejuni Species 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 241001247437 Cerbera odollam Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241001647372 Chlamydia pneumoniae Species 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 241000606153 Chlamydia trachomatis Species 0.000 description 1
• 241001185363 Chlamydiae Species 0.000 description 1
• 108010049048 Cholera Toxin Proteins 0.000 description 1
• 102000009016 Cholera Toxin Human genes 0.000 description 1
• 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 241000193155 Clostridium botulinum Species 0.000 description 1
• 241000193449 Clostridium tetani Species 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000484025 Cuniculus Species 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 102000012410 DNA Ligases Human genes 0.000 description 1
• 108010061982 DNA Ligases Proteins 0.000 description 1
• 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 1
• 101100481408 Danio rerio tie2 gene Proteins 0.000 description 1
• 206010011968 Decreased immune responsiveness Diseases 0.000 description 1
• 102100031262 Deleted in malignant brain tumors 1 protein Human genes 0.000 description 1
• 241000725619 Dengue virus Species 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 108010053187 Diphtheria Toxin Proteins 0.000 description 1
• 102000016607 Diphtheria Toxin Human genes 0.000 description 1
• 241000605314 Ehrlichia Species 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 241000224431 Entamoeba Species 0.000 description 1
• 241001133638 Entamoeba equi Species 0.000 description 1
• 241000224432 Entamoeba histolytica Species 0.000 description 1
• 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 1
• 241000194033 Enterococcus Species 0.000 description 1
• 241000194032 Enterococcus faecalis Species 0.000 description 1
• 241000194031 Enterococcus faecium Species 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
• 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 1
• 241000588722 Escherichia Species 0.000 description 1
• 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 1
• 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 1
• 101000738180 Euglena gracilis Chaperonin CPN60, mitochondrial Proteins 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
• 239000001828 Gelatine Substances 0.000 description 1
• 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
• 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 1
• 101800001586 Ghrelin Proteins 0.000 description 1
• 102400000442 Ghrelin-28 Human genes 0.000 description 1
• 241000224466 Giardia Species 0.000 description 1
• 241000224467 Giardia intestinalis Species 0.000 description 1
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 206010018473 Glycosuria Diseases 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 241000606790 Haemophilus Species 0.000 description 1
• 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 1
• 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 1
• 101100406392 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) omp26 gene Proteins 0.000 description 1
• 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
• 102100026973 Heat shock protein 75 kDa, mitochondrial Human genes 0.000 description 1
• 101710130649 Heat shock protein 75 kDa, mitochondrial Proteins 0.000 description 1
• 241000589989 Helicobacter Species 0.000 description 1
• 101710154606 Hemagglutinin Proteins 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• 241000724675 Hepatitis E virus Species 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 101000985215 Homo sapiens 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
• 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
• 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 1
• 101001010591 Homo sapiens Interleukin-20 Proteins 0.000 description 1
• 101100346929 Homo sapiens MUC1 gene Proteins 0.000 description 1
• 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 description 1
• 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
• 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 description 1
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 description 1
• 101000780643 Homo sapiens Protein argonaute-2 Proteins 0.000 description 1
• 101001130441 Homo sapiens Ras-related protein Rap-2a Proteins 0.000 description 1
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
• 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 101000854936 Homo sapiens Visual system homeobox 1 Proteins 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
• 206010071038 Human anaplasmosis Diseases 0.000 description 1
• 101150027427 ICP4 gene Proteins 0.000 description 1
• 102000026633 IL6 Human genes 0.000 description 1
• 108091058560 IL8 Proteins 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100034353 Integrase Human genes 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 101800003050 Interleukin-16 Proteins 0.000 description 1
• 102000049772 Interleukin-16 Human genes 0.000 description 1
• 102100033461 Interleukin-17A Human genes 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102100030692 Interleukin-20 Human genes 0.000 description 1
• 102100030704 Interleukin-21 Human genes 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 102000000704 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000000585 Interleukin-9 Human genes 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 1
• 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 1
• 102100032241 Lactotransferrin Human genes 0.000 description 1
• 101710128836 Large T antigen Proteins 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 241000589242 Legionella pneumophila Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 1
• 241000589902 Leptospira Species 0.000 description 1
• 241000589929 Leptospira interrogans Species 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 101710151321 Melanostatin Proteins 0.000 description 1
• 102100026712 Metalloreductase STEAP1 Human genes 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 1
• 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 1
• 101710145242 Minor capsid protein P3-RTD Proteins 0.000 description 1
• 241000588621 Moraxella Species 0.000 description 1
• 241000588622 Moraxella bovis Species 0.000 description 1
• 241000588655 Moraxella catarrhalis Species 0.000 description 1
• 101100508420 Mus musculus Ifng gene Proteins 0.000 description 1
• 101100369076 Mus musculus Tdgf1 gene Proteins 0.000 description 1
• 101100481410 Mus musculus Tek gene Proteins 0.000 description 1
• 241000186359 Mycobacterium Species 0.000 description 1
• 241000186367 Mycobacterium avium Species 0.000 description 1
• 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 description 1
• 241000186362 Mycobacterium leprae Species 0.000 description 1
• 241000187480 Mycobacterium smegmatis Species 0.000 description 1
• 101100054729 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) hspX gene Proteins 0.000 description 1
• 101100361221 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) rpfC gene Proteins 0.000 description 1
• 101100361225 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) rpfD gene Proteins 0.000 description 1
• 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 241000588650 Neisseria meningitidis Species 0.000 description 1
• 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
• 102400000064 Neuropeptide Y Human genes 0.000 description 1
• 102100037571 Neurosecretory protein VGF Human genes 0.000 description 1
• 101710144128 Non-structural protein 2 Proteins 0.000 description 1
• 101710144111 Non-structural protein 3 Proteins 0.000 description 1
• 101800001020 Non-structural protein 4A Proteins 0.000 description 1
• 101800001019 Non-structural protein 4B Proteins 0.000 description 1
• 101800001014 Non-structural protein 5A Proteins 0.000 description 1
• 101710199667 Nuclear export protein Proteins 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• HCUVEUVIUAJXRB-UHFFFAOYSA-N OC1=C(C=C(CNC(CCCC=2SC=CC=2)=O)C=C1)OC Chemical compound OC1=C(C=C(CNC(CCCC=2SC=CC=2)=O)C=C1)OC HCUVEUVIUAJXRB-UHFFFAOYSA-N 0.000 description 1
• 108090000630 Oncostatin M Proteins 0.000 description 1
• 102100031942 Oncostatin-M Human genes 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
• 101710116435 Outer membrane protein Proteins 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 229910018828 PO3H2 Inorganic materials 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 102000036673 PRAME Human genes 0.000 description 1
• 108060006580 PRAME Proteins 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 108010081690 Pertussis Toxin Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 1
• 101710099976 Photosystem I P700 chlorophyll a apoprotein A1 Proteins 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 101000983333 Plasmodium falciparum (isolate NF54) 25 kDa ookinete surface antigen Proteins 0.000 description 1
• 206010035500 Plasmodium falciparum infection Diseases 0.000 description 1
• 241000233870 Pneumocystis Species 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 101710183389 Pneumolysin Proteins 0.000 description 1
• 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
• 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
• 102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 102100036735 Prostate stem cell antigen Human genes 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710176177 Protein A56 Proteins 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 101710192141 Protein Nef Proteins 0.000 description 1
• 102100037977 Protein phosphatase inhibitor 2 family member C Human genes 0.000 description 1
• 101710135630 Protein phosphatase inhibitor 2 family member C Proteins 0.000 description 1
• 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 1
• 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 1
• 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 1
• 101710201576 Putative membrane protein Proteins 0.000 description 1
• 102100022851 Rab5 GDP/GTP exchange factor Human genes 0.000 description 1
• 102100031420 Ras-related protein Rap-2a Human genes 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 101710203837 Replication-associated protein Proteins 0.000 description 1
• 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 1
• 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 1
• 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 1
• 241000606701 Rickettsia Species 0.000 description 1
• 241000606695 Rickettsia rickettsii Species 0.000 description 1
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 101100468774 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RIM13 gene Proteins 0.000 description 1
• 101000999689 Saimiriine herpesvirus 2 (strain 11) Transcriptional regulator ICP22 homolog Proteins 0.000 description 1
• 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 1
• 241001138501 Salmonella enterica Species 0.000 description 1
• 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
• 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
• 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
• 241000607149 Salmonella sp. Species 0.000 description 1
• 241000242680 Schistosoma mansoni Species 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 241000607764 Shigella dysenteriae Species 0.000 description 1
• 241000607760 Shigella sonnei Species 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 101150081875 Slc7a10 gene Proteins 0.000 description 1
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 244000300264 Spinacia oleracea Species 0.000 description 1
• 235000009337 Spinacia oleracea Nutrition 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000191963 Staphylococcus epidermidis Species 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 206010061372 Streptococcal infection Diseases 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000193985 Streptococcus agalactiae Species 0.000 description 1
• 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 1
• 241000194019 Streptococcus mutans Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 108010011834 Streptolysins Proteins 0.000 description 1
• 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 1
• 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 1
• 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 1
• 101710198996 Sucrose-binding protein Proteins 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 101710137302 Surface antigen S Proteins 0.000 description 1
• 108010002687 Survivin Proteins 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 229920006355 Tefzel Polymers 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 241000710771 Tick-borne encephalitis virus Species 0.000 description 1
• 102000057032 Tissue Kallikreins Human genes 0.000 description 1
• 108700022175 Tissue Kallikreins Proteins 0.000 description 1
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
• 102100039387 Toll-like receptor 6 Human genes 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 241000223997 Toxoplasma gondii Species 0.000 description 1
• 201000005485 Toxoplasmosis Diseases 0.000 description 1
• 101710134694 Transcriptional regulator ICP22 homolog Proteins 0.000 description 1
• 102000010912 Transferrin-Binding Proteins Human genes 0.000 description 1
• 108010062476 Transferrin-Binding Proteins Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 241000589886 Treponema Species 0.000 description 1
• 241000589892 Treponema denticola Species 0.000 description 1
• 241000589884 Treponema pallidum Species 0.000 description 1
• 241000224526 Trichomonas Species 0.000 description 1
• 241000224527 Trichomonas vaginalis Species 0.000 description 1
• 241000223104 Trypanosoma Species 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Chemical group C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 206010064390 Tumour invasion Diseases 0.000 description 1
• 102100039094 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 101800003344 Vaccinia growth factor Proteins 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 101800001863 Variola growth factor Proteins 0.000 description 1
• 241000607598 Vibrio Species 0.000 description 1
• 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 1
• 241000607626 Vibrio cholerae Species 0.000 description 1
• 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 1
• 108700005077 Viral Genes Proteins 0.000 description 1
• 102100020673 Visual system homeobox 1 Human genes 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
• 241000606834 [Haemophilus] ducreyi Species 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 101150094017 aceA gene Proteins 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 108091005764 adaptor proteins Proteins 0.000 description 1
• 102000035181 adaptor proteins Human genes 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 229960003767 alanine Drugs 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 125000004414 alkyl thio group Chemical group 0.000 description 1
• 239000013566 allergen Substances 0.000 description 1
• 101150078331 ama-1 gene Proteins 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
• 239000003098 androgen Substances 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 229940041181 antineoplastic drug Drugs 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 239000013011 aqueous formulation Substances 0.000 description 1
• SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 101150070136 axeA gene Proteins 0.000 description 1
• 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
• 201000008680 babesiosis Diseases 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 229960001212 bacterial vaccine Drugs 0.000 description 1
• 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 201000001531 bladder carcinoma Diseases 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 229960003150 bupivacaine Drugs 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000004900 c-terminal fragment Anatomy 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 125000000837 carbohydrate group Chemical group 0.000 description 1
• 210000004413 cardiac myocyte Anatomy 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 108091016312 choline binding proteins Proteins 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 239000007891 compressed tablet Substances 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 239000003433 contraceptive agent Substances 0.000 description 1
• 230000002254 contraceptive effect Effects 0.000 description 1
• 229940124462 contraceptive vaccine Drugs 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 239000000428 dust Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000006274 endogenous ligand Substances 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 230000000369 enteropathogenic effect Effects 0.000 description 1
• 231100000249 enterotoxic Toxicity 0.000 description 1
• 230000002242 enterotoxic effect Effects 0.000 description 1
• 108010078428 env Gene Products Proteins 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• ZINJLDJMHCUBIP-UHFFFAOYSA-N ethametsulfuron-methyl Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(=O)OC)=N1 ZINJLDJMHCUBIP-UHFFFAOYSA-N 0.000 description 1
• QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical compound C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 239000006277 exogenous ligand Substances 0.000 description 1
• 101150028082 fbpA gene Proteins 0.000 description 1
• 239000000834 fixative Substances 0.000 description 1
• 238000011990 functional testing Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 108700004026 gag Genes Proteins 0.000 description 1
• 101150098622 gag gene Proteins 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 125000001188 haloalkyl group Chemical group 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 239000001307 helium Substances 0.000 description 1
• 229910052734 helium Inorganic materials 0.000 description 1
• SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 102000046157 human CSF2 Human genes 0.000 description 1
• 102000057860 human MUC1 Human genes 0.000 description 1
• 201000009163 human granulocytic anaplasmosis Diseases 0.000 description 1
• 208000022340 human granulocytic ehrlichiosis Diseases 0.000 description 1
• 244000052637 human pathogen Species 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 125000005113 hydroxyalkoxy group Chemical group 0.000 description 1
• 238000010191 image analysis Methods 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 229960001438 immunostimulant agent Drugs 0.000 description 1
• 239000003022 immunostimulating agent Substances 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 208000037798 influenza B Diseases 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 229940065638 intron a Drugs 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 235000014705 isoleucine Nutrition 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 230000001050 lubricating effect Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000003866 lung sarcoma Diseases 0.000 description 1
• 230000001592 luteinising effect Effects 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 101710130522 mRNA export factor Proteins 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000003595 mist Substances 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 150000002772 monosaccharides Chemical class 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 239000007923 nasal drop Substances 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 210000001331 nose Anatomy 0.000 description 1
• URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 229960003126 other bacterial vaccines in atc Drugs 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 239000003415 peat Substances 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 108010021711 pertactin Proteins 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical group OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 229960005190 phenylalanine Drugs 0.000 description 1
• 235000008729 phenylalanine Nutrition 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 201000000317 pneumocystosis Diseases 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 description 1
• 230000008092 positive effect Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000012743 protein tagging Effects 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000021670 response to stimulus Effects 0.000 description 1
• 229940064914 retrovir Drugs 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• 235000002020 sage Nutrition 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 238000007493 shaping process Methods 0.000 description 1
• 229940063673 spermidine Drugs 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 229940031626 subunit vaccine Drugs 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 229940032362 superoxide dismutase Drugs 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 229940021747 therapeutic vaccine Drugs 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 230000014616 translation Effects 0.000 description 1
• 102000027257 transmembrane receptors Human genes 0.000 description 1
• 108091008578 transmembrane receptors Proteins 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 201000002311 trypanosomiasis Diseases 0.000 description 1
• 230000001810 trypsinlike Effects 0.000 description 1
• 229960004799 tryptophan Drugs 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 230000002477 vacuolizing effect Effects 0.000 description 1
• 229960004295 valine Drugs 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 235000014393 valine Nutrition 0.000 description 1
• 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 244000052613 viral pathogen Species 0.000 description 1
• 229960004854 viral vaccine Drugs 0.000 description 1
• 239000007762 w/o emulsion Substances 0.000 description 1
• 239000008215 water for injection Substances 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1
• HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 1